Qualia Life Sciences
13
1
1
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 13 trials
100.0%
+13.4% vs industry average
0%
0 trials in Phase 3/4
50%
1 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (13)
Comparison of Four Qualia Sleep Formulations on Sleep Quality : An Open-label 4-arm Pilot Study
Role: lead
The Impact of Qualia Vitamin C+ on Individuals With Suboptimal and Adequate Vitamin C Levels
Role: lead
Effectiveness of Qualia NAD+ Supplementation on NAD Levels
Role: lead
The Impact of Qualia Vitamin C+ on Blood Vitamin C Levels
Role: lead
Efficacy of Qualia Testosterone+ on Testosterone Levels in Adult Males
Role: lead
Qualia Perimenopause Efficacy and Tolerability Study: An Open-label 3-Arm Trial
Role: lead
The Impact of Qualia Gluthathione+ on Blood Glutathione Levels
Role: lead
Impact of Two Iron Formulations on Iron Biomarkers and Quality of Life
Role: lead
Comparison of Two Qualia NAD⁺ Formulations on Intracellular NAD⁺ Levels
Role: lead
Effectiveness of Qualia Testosterone Supplementation on Testosterone Levels
Role: lead
Effectiveness of Qualia Magnesium+® Supplementation on RBC Magnesium Levels
Role: lead
An Open-Label Pilot Study of Qualia Senolytic Supplementation for the Attenuation of Systemic Inflammatory Cytokines
Role: lead
Effectiveness of Qualia NAD+ Supplementation on Intracellular NAD Levels
Role: lead
All 13 trials loaded